Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19369092rdf:typepubmed:Citationlld:pubmed
pubmed-article:19369092lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:19369092lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19369092lifeskim:mentionsumls-concept:C0920317lld:lifeskim
pubmed-article:19369092lifeskim:mentionsumls-concept:C0935916lld:lifeskim
pubmed-article:19369092lifeskim:mentionsumls-concept:C0282440lld:lifeskim
pubmed-article:19369092lifeskim:mentionsumls-concept:C1955832lld:lifeskim
pubmed-article:19369092lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:19369092pubmed:issue3lld:pubmed
pubmed-article:19369092pubmed:dateCreated2010-2-1lld:pubmed
pubmed-article:19369092pubmed:abstractTextTo compare efficacy and tolerability of fulvestrant with aromatase inhibitors and tamoxifen that actually represent the standard of care in hormone-sensitive breast cancer.lld:pubmed
pubmed-article:19369092pubmed:languageenglld:pubmed
pubmed-article:19369092pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19369092pubmed:citationSubsetIMlld:pubmed
pubmed-article:19369092pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19369092pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19369092pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19369092pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19369092pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19369092pubmed:statusMEDLINElld:pubmed
pubmed-article:19369092pubmed:monthMarlld:pubmed
pubmed-article:19369092pubmed:issn1879-0461lld:pubmed
pubmed-article:19369092pubmed:authorpubmed-author:GeorgouliasVa...lld:pubmed
pubmed-article:19369092pubmed:authorpubmed-author:MauriDavideDlld:pubmed
pubmed-article:19369092pubmed:authorpubmed-author:MavroudisDimi...lld:pubmed
pubmed-article:19369092pubmed:authorpubmed-author:CasazzaGiovan...lld:pubmed
pubmed-article:19369092pubmed:authorpubmed-author:PolyzosNikola...lld:pubmed
pubmed-article:19369092pubmed:authorpubmed-author:ValachisAnton...lld:pubmed
pubmed-article:19369092pubmed:copyrightInfoCopyright 2009 Elsevier Ireland Ltd. All rights reserved.lld:pubmed
pubmed-article:19369092pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19369092pubmed:volume73lld:pubmed
pubmed-article:19369092pubmed:ownerNLMlld:pubmed
pubmed-article:19369092pubmed:authorsCompleteYlld:pubmed
pubmed-article:19369092pubmed:pagination220-7lld:pubmed
pubmed-article:19369092pubmed:meshHeadingpubmed-meshheading:19369092...lld:pubmed
pubmed-article:19369092pubmed:meshHeadingpubmed-meshheading:19369092...lld:pubmed
pubmed-article:19369092pubmed:meshHeadingpubmed-meshheading:19369092...lld:pubmed
pubmed-article:19369092pubmed:meshHeadingpubmed-meshheading:19369092...lld:pubmed
pubmed-article:19369092pubmed:meshHeadingpubmed-meshheading:19369092...lld:pubmed
pubmed-article:19369092pubmed:meshHeadingpubmed-meshheading:19369092...lld:pubmed
pubmed-article:19369092pubmed:meshHeadingpubmed-meshheading:19369092...lld:pubmed
pubmed-article:19369092pubmed:meshHeadingpubmed-meshheading:19369092...lld:pubmed
pubmed-article:19369092pubmed:year2010lld:pubmed
pubmed-article:19369092pubmed:articleTitleFulvestrant in the treatment of advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials.lld:pubmed
pubmed-article:19369092pubmed:affiliationDepartment of Medical Oncology, University General Hospital of Heraklion, Greece.lld:pubmed
pubmed-article:19369092pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19369092pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:19369092pubmed:publicationTypeReviewlld:pubmed
pubmed-article:19369092pubmed:publicationTypeMeta-Analysislld:pubmed